Pfizer Inc
SWB:PFE

Watchlist Manager
Pfizer Inc Logo
Pfizer Inc
SWB:PFE
Watchlist
Price: 21.66 EUR -0.44%
Market Cap: 123.2B EUR

Relative Value

The Relative Value of one PFE stock under the Base Case scenario is hidden EUR. Compared to the current market price of 21.66 EUR, Pfizer Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PFE Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
69
vs Industry
47
Median 3Y
2.4
Median 5Y
2.5
Industry
2.6
Forward
2.3
vs History
42
vs Industry
26
Median 3Y
14
Median 5Y
13.8
Industry
21.4
Forward
8.1
vs History
46
vs Industry
31
Median 3Y
11.8
Median 5Y
10.8
Industry
16.4
vs History
9
vs Industry
23
Median 3Y
11.7
Median 5Y
9.4
Industry
22.8
vs History
87
vs Industry
47
Median 3Y
1.7
Median 5Y
2
Industry
2.2
vs History
50
vs Industry
36
Median 3Y
2.9
Median 5Y
3
Industry
2.9
Forward
3
vs History
63
vs Industry
46
Median 3Y
4
Median 5Y
4.3
Industry
5.5
vs History
58
vs Industry
36
Median 3Y
7.6
Median 5Y
8
Industry
13
Forward
7.7
vs History
57
vs Industry
33
Median 3Y
10.4
Median 5Y
10.7
Industry
16.5
Forward
8.7
vs History
30
vs Industry
25
Median 3Y
14.2
Median 5Y
13
Industry
15.6
vs History
34
vs Industry
20
Median 3Y
19.1
Median 5Y
16
Industry
18.7
vs History
82
vs Industry
58
Median 3Y
1
Median 5Y
1.2
Industry
1.9

Multiples Across Competitors

PFE Competitors Multiples
Pfizer Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Pfizer Inc
SWB:PFE
144.8B EUR 2.3 14.7 7.5 10.2
US
Eli Lilly and Co
NYSE:LLY
1T USD 17.6 56.7 38 40.7
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
498.5B USD 5.4 19.8 16.2 21.1
CH
Roche Holding AG
SIX:ROG
268.8B CHF 4.4 28.5 12.1 14.2
UK
AstraZeneca PLC
LSE:AZN
219.6B GBP 5.1 31.5 108.7 159.1
US
Merck & Co Inc
NYSE:MRK
277.5B USD 4.3 14.6 10.3 12.2
CH
Novartis AG
SIX:NOVN
219.4B CHF 4.9 19.1 12.1 15.6
DK
Novo Nordisk A/S
CSE:NOVO B
1.6T DKK 5.1 15.6 10.9 12.6
IE
Endo International PLC
LSE:0Y5F
213.9B USD 92.2 -73.2 338.7 849.2
FR
Sanofi SA
PAR:SAN
101.1B EUR 1.5 7.3 6.7 6.7
P/E Multiple
Earnings Growth PEG
US
Pfizer Inc
SWB:PFE
Average P/E: 23.1
14.7
27%
0.5
US
Eli Lilly and Co
NYSE:LLY
56.7
54%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.8
29%
0.7
CH
Roche Holding AG
SIX:ROG
28.5
29%
1
UK
AstraZeneca PLC
LSE:AZN
31.5
37%
0.9
US
Merck & Co Inc
NYSE:MRK
14.6
15%
1
CH
Novartis AG
SIX:NOVN
19.1
17%
1.1
DK
Novo Nordisk A/S
CSE:NOVO B
15.6
3%
5.2
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -73.2 N/A N/A
FR
Sanofi SA
PAR:SAN
7.3
26%
0.3
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Pfizer Inc
SWB:PFE
Average EV/EBITDA: 400.7
7.5
0%
N/A
US
Eli Lilly and Co
NYSE:LLY
38
34%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.2
9%
1.8
CH
Roche Holding AG
SIX:ROG
12.1
5%
2.4
UK
AstraZeneca PLC
LSE:AZN
108.7
10%
10.9
US
Merck & Co Inc
NYSE:MRK
10.3
6%
1.7
CH
Novartis AG
SIX:NOVN
12.1
6%
2
DK
Novo Nordisk A/S
CSE:NOVO B
10.9
1%
10.9
IE
E
Endo International PLC
LSE:0Y5F
338.7
N/A N/A
FR
Sanofi SA
PAR:SAN
6.7
8%
0.8
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Pfizer Inc
SWB:PFE
Average EV/EBIT: 1 713.1
10.2
7%
1.5
US
Eli Lilly and Co
NYSE:LLY
40.7
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21.1
15%
1.4
CH
Roche Holding AG
SIX:ROG
14.2
6%
2.4
UK
AstraZeneca PLC
LSE:AZN
159.1
23%
6.9
US
Merck & Co Inc
NYSE:MRK
12.2
8%
1.5
CH
Novartis AG
SIX:NOVN
15.6
12%
1.3
DK
Novo Nordisk A/S
CSE:NOVO B
12.6
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
849.2
N/A N/A
FR
Sanofi SA
PAR:SAN
6.7
15%
0.4